Liver fat and fibrosis are biomarkers of cardio-vascular risk in patients with diabetes mellitus
With the increased prevalence of metabolic syndrome, imaging now plays an additional prognostic role, especially in the personalization of cardio-vascular events. This paper prospectively shows the importance of liver disease and its relationship with epicardial adipose tissue (EAT) in this regard. It offers a new insight into basic CT examinations.
- EAT volume is higher in diabetic individuals with NAFLD
- Liver fat content is positively correlated with EAT
- Liver fat content and liver fibrosis were independently associated with EAT
- Higher liver fat content and fibrosis may adversely affect cardiovascular risk
Authors: Sharon S. Brouha, Phrium Nguyen, Ricki Bettencourt, Claude S. Sirlin and Rohit Loomba